Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024
“Increasing prevalence of infectious diseases is expected to drive the overall growth of the OTC Test market.”
The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during forecast period. Diabetes is a prominent affliction across the globe and a key contributor to the demand for OTC tests. Infectious diseases also require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.
“The infectious disease tests segment is expected to grow at the highest CAGR during the forecast period.”
The OTC Test market, by product, has been categorized into eight major segments— glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and other tests. The infectious disease tests segment is estimated to grow at the highest CAGR during the forecast period. This market is majorly driven by factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In the OTC Test market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for OTC Test in the Asia Pacific. Increasing prevalence of target conditions and infectious diseases and growing patient population base in emerging countries like India and China are expected to drive the growth of these markets during the forecast period.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the OTC Test market.
Research Coverage:
The market study covers the OTC Test market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall OTC Test market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.
The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during forecast period. Diabetes is a prominent affliction across the globe and a key contributor to the demand for OTC tests. Infectious diseases also require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.
“The infectious disease tests segment is expected to grow at the highest CAGR during the forecast period.”
The OTC Test market, by product, has been categorized into eight major segments— glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and other tests. The infectious disease tests segment is estimated to grow at the highest CAGR during the forecast period. This market is majorly driven by factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In the OTC Test market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for OTC Test in the Asia Pacific. Increasing prevalence of target conditions and infectious diseases and growing patient population base in emerging countries like India and China are expected to drive the growth of these markets during the forecast period.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the OTC Test market.
- By Company Type: Tier 1–18%, Tier 2–39%, and Tier 3–43%
- By Designation: C-level Executives–25%, Directors–20%, and Others–55%
- By Region: North America–40%, Europe–27%, APAC–20%, and RoW–13%
Research Coverage:
The market study covers the OTC Test market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall OTC Test market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS COVERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 PRIMARY DATA
2.1.1 KEY DATA FROM PRIMARY SOURCES
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4.1 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OTC TESTS: MARKET OVERVIEW
4.2 OTC TESTS MARKET, BY TECHNOLOGY (2018–2024)
4.3 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT (2018)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetes
5.2.1.2 High prevalence of infectious diseases in developing countries
5.2.1.3 Growing support and collaboration for developing OTC tests
5.2.2 OPPORTUNITIES
5.2.2.1 Introduction of combined kits for testing pregnancy and ovulation
5.2.3 CHALLENGES
5.2.3.1 Invasiveness of blood glucose monitors and cholesterol monitors
6 OVER THE COUNTER TESTS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 LATERAL FLOW ASSAYS
6.2.1 LATERAL FLOW ASSAYS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
6.3 IMMUNOASSAYS
6.3.1 INCREASING USE OF IMMUNOASSAYS FOR PREGNANCY & INFECTIOUS DISEASE TESTING IS DRIVING MARKET GROWTH
6.4 DIPSTICKS
6.4.1 DIPSTICKS PROVIDE ONLY A QUALITATIVE ANALYSIS, WHICH IS A MAJOR FACTOR RESTRAINING MARKET GROWTH
7 OVER THE COUNTER TESTS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 GLUCOSE MONITORING TESTS
7.2.1 GLUCOSE MONITORING TESTS DOMINATED THE OTC TESTS MARKET IN 2018
7.3 PREGNANCY & FERTILITY TESTS
7.3.1 ADVANTAGES OF PREGNANCY & FERTILITY TESTS HAVE DRIVEN COMPANIES TO FOCUS ON PRODUCT DEVELOPMENT
7.4 INFECTIOUS DISEASE TESTS
7.4.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES IS DRIVING MARKET GROWTH
7.5 COAGULATION MONITORING TESTS
7.5.1 COAGULATION MONITORING TESTS PROVIDE QUICK AND RELIABLE RESULTS
7.6 URINALYSIS TESTS
7.6.1 INCREASING PREVALENCE OF URINARY TRACT INFECTIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH
7.7 CHOLESTEROL TESTS
7.7.1 CONVENIENCE OF HOME-USE TESTS HAS EXPANDED THEIR USE
7.8 DRUGS-OF-ABUSE TESTS
7.8.1 RISING PRODUCTION AND CONSUMPTION OF ILLEGAL DRUGS HAVE DRIVEN THE FOCUS ON TESTING
7.9 OTHER TESTS
8 OVER THE COUNTER TESTS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 US to dominate the North America OTC tests market
8.2.2 CANADA
8.2.2.1 Increasing government initiatives to support the adoption of POC products to drive market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 Germany is the fastest-growing market in Europe
8.3.2 FRANCE
8.3.2.1 High demand for glucose testing kits to drive market growth in France
8.3.3 UK
8.3.3.1 Increasing awareness of OCT tests among the users
8.3.4 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL OTC TESTS MARKET
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 VENDOR BENCHMARKING
9.3 COMPETITIVE LEADERSHIP MAPPING
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 DYNAMIC DIFFERENTIATORS
9.3.4 EMERGING COMPANIES
9.4 MARKET RANKING ANALYSIS, 2017
9.5 COMPETITIVE SITUATION AND TRENDS
9.5.1 PRODUCT LAUNCHES
9.5.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
9.5.3 ACQUISITIONS
10 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 ROCHE DIAGNOSTICS
10.2 ABBOTT LABORATORIES
10.3 ORASURE TECHNOLOGIES
10.4 ACCUBIOTECH
10.5 LIA DIAGNOSTICS
10.6 LABSTYLE INNOVATIONS
10.7 SD BIOSENSOR
10.8 ACON LABORATORIES INC
10.9 SINOCARE
10.10 NOWDIAGNOSTICS COMPANY
10.11 I HEALTH LAB
10.12 BIOLYTICAL LABORATORIES
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS COVERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 PRIMARY DATA
2.1.1 KEY DATA FROM PRIMARY SOURCES
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4.1 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OTC TESTS: MARKET OVERVIEW
4.2 OTC TESTS MARKET, BY TECHNOLOGY (2018–2024)
4.3 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT (2018)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetes
5.2.1.2 High prevalence of infectious diseases in developing countries
5.2.1.3 Growing support and collaboration for developing OTC tests
5.2.2 OPPORTUNITIES
5.2.2.1 Introduction of combined kits for testing pregnancy and ovulation
5.2.3 CHALLENGES
5.2.3.1 Invasiveness of blood glucose monitors and cholesterol monitors
6 OVER THE COUNTER TESTS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 LATERAL FLOW ASSAYS
6.2.1 LATERAL FLOW ASSAYS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
6.3 IMMUNOASSAYS
6.3.1 INCREASING USE OF IMMUNOASSAYS FOR PREGNANCY & INFECTIOUS DISEASE TESTING IS DRIVING MARKET GROWTH
6.4 DIPSTICKS
6.4.1 DIPSTICKS PROVIDE ONLY A QUALITATIVE ANALYSIS, WHICH IS A MAJOR FACTOR RESTRAINING MARKET GROWTH
7 OVER THE COUNTER TESTS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 GLUCOSE MONITORING TESTS
7.2.1 GLUCOSE MONITORING TESTS DOMINATED THE OTC TESTS MARKET IN 2018
7.3 PREGNANCY & FERTILITY TESTS
7.3.1 ADVANTAGES OF PREGNANCY & FERTILITY TESTS HAVE DRIVEN COMPANIES TO FOCUS ON PRODUCT DEVELOPMENT
7.4 INFECTIOUS DISEASE TESTS
7.4.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES IS DRIVING MARKET GROWTH
7.5 COAGULATION MONITORING TESTS
7.5.1 COAGULATION MONITORING TESTS PROVIDE QUICK AND RELIABLE RESULTS
7.6 URINALYSIS TESTS
7.6.1 INCREASING PREVALENCE OF URINARY TRACT INFECTIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH
7.7 CHOLESTEROL TESTS
7.7.1 CONVENIENCE OF HOME-USE TESTS HAS EXPANDED THEIR USE
7.8 DRUGS-OF-ABUSE TESTS
7.8.1 RISING PRODUCTION AND CONSUMPTION OF ILLEGAL DRUGS HAVE DRIVEN THE FOCUS ON TESTING
7.9 OTHER TESTS
8 OVER THE COUNTER TESTS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 US to dominate the North America OTC tests market
8.2.2 CANADA
8.2.2.1 Increasing government initiatives to support the adoption of POC products to drive market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 Germany is the fastest-growing market in Europe
8.3.2 FRANCE
8.3.2.1 High demand for glucose testing kits to drive market growth in France
8.3.3 UK
8.3.3.1 Increasing awareness of OCT tests among the users
8.3.4 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL OTC TESTS MARKET
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 VENDOR BENCHMARKING
9.3 COMPETITIVE LEADERSHIP MAPPING
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 DYNAMIC DIFFERENTIATORS
9.3.4 EMERGING COMPANIES
9.4 MARKET RANKING ANALYSIS, 2017
9.5 COMPETITIVE SITUATION AND TRENDS
9.5.1 PRODUCT LAUNCHES
9.5.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
9.5.3 ACQUISITIONS
10 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 ROCHE DIAGNOSTICS
10.2 ABBOTT LABORATORIES
10.3 ORASURE TECHNOLOGIES
10.4 ACCUBIOTECH
10.5 LIA DIAGNOSTICS
10.6 LABSTYLE INNOVATIONS
10.7 SD BIOSENSOR
10.8 ACON LABORATORIES INC
10.9 SINOCARE
10.10 NOWDIAGNOSTICS COMPANY
10.11 I HEALTH LAB
10.12 BIOLYTICAL LABORATORIES
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2017 VS. 2045 (MILLION)
TABLE 2 OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 3 OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2016–2024 (USD MILLION)
TABLE 4 NORTH AMERICA: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 5 EUROPE: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 6 OTC TESTS MARKET FOR IMMUNOASSAYS, BY REGION, 2016–2024 (USD MILLION)
TABLE 7 NORTH AMERICA: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 8 EUROPE: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 9 OTC TESTS MARKET FOR DIPSTICKS, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 NORTH AMERICA: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 11 EUROPE: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 12 OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 13 OTC GLUCOSE MONITORING TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 14 NORTH AMERICA: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 15 EUROPE: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 16 OTC PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 18 EUROPE: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 19 OTC INFECTIOUS DISEASE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 21 EUROPE: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 22 OTC COAGULATION MONITORING TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 24 EUROPE: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 25 OTC URINALYSIS TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: OTC URINALYSIS TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 27 EUROPE: OTC URINALYSIS TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 28 OTC CHOLESTEROL TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 30 EUROPE: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 31 OTC DRUGS-OF-ABUSE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 33 EUROPE: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 34 OTC OTHER TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 35 NORTH AMERICA: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 36 EUROPE: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 37 OTC TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 38 NORTH AMERICA: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 39 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 41 US: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 42 US: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 43 CANADA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 44 CANADA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 45 EUROPE: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 46 EUROPE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 47 EUROPE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 48 GERMANY: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 49 GERMANY: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 50 FRANCE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 51 FRANCE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 52 UK: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 53 UK: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 54 ROE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 55 ROE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 56 APAC: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 57 APAC: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 58 ROW: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 59 ROW: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 60 PRODUCT LAUNCHES, 2016–2019
TABLE 61 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2019
TABLE 62 ACQUISITIONS, 2016-2019
TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2017 VS. 2045 (MILLION)
TABLE 2 OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 3 OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2016–2024 (USD MILLION)
TABLE 4 NORTH AMERICA: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 5 EUROPE: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 6 OTC TESTS MARKET FOR IMMUNOASSAYS, BY REGION, 2016–2024 (USD MILLION)
TABLE 7 NORTH AMERICA: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 8 EUROPE: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 9 OTC TESTS MARKET FOR DIPSTICKS, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 NORTH AMERICA: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 11 EUROPE: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 12 OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 13 OTC GLUCOSE MONITORING TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 14 NORTH AMERICA: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 15 EUROPE: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 16 OTC PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 18 EUROPE: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 19 OTC INFECTIOUS DISEASE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 21 EUROPE: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 22 OTC COAGULATION MONITORING TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 24 EUROPE: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 25 OTC URINALYSIS TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: OTC URINALYSIS TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 27 EUROPE: OTC URINALYSIS TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 28 OTC CHOLESTEROL TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 30 EUROPE: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 31 OTC DRUGS-OF-ABUSE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 33 EUROPE: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 34 OTC OTHER TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 35 NORTH AMERICA: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 36 EUROPE: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 37 OTC TESTS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 38 NORTH AMERICA: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 39 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 41 US: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 42 US: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 43 CANADA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 44 CANADA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 45 EUROPE: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 46 EUROPE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 47 EUROPE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 48 GERMANY: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 49 GERMANY: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 50 FRANCE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 51 FRANCE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 52 UK: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 53 UK: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 54 ROE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 55 ROE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 56 APAC: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 57 APAC: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 58 ROW: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 59 ROW: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 60 PRODUCT LAUNCHES, 2016–2019
TABLE 61 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2019
TABLE 62 ACQUISITIONS, 2016-2019
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION
FIGURE 6 OTC TESTS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION)
FIGURE 7 OTC TESTS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OTC TESTS MARKET
FIGURE 9 RISING PREVALENCE OF TARGET DISEASES AND DISORDERS IS A KEY DRIVER FOR THE OTC TESTS MARKET
FIGURE 10 LATERAL FLOW ASSAYS TO CONTINUE TO DOMINATE THE OTC TESTS
MARKET IN 2024
FIGURE 11 GLUCOSE MONITORING TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN OTC TESTS MARKET IN 2018
FIGURE 12 OTC TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 NORTH AMERICA: OTC TESTS MARKET SNAPSHOT
FIGURE 14 APAC: OTC TESTS MARKET SNAPSHOT
FIGURE 15 OTC TESTS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
FIGURE 16 RANK OF COMPANIES IN THE GLOBAL OTC TESTS MARKET, 2017
FIGURE 17 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2018)
FIGURE 18 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
FIGURE 19 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2017)
FIGURE 20 LABSTYLE INNOVATIONS: COMPANY SNAPSHOT (2017)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION
FIGURE 6 OTC TESTS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION)
FIGURE 7 OTC TESTS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OTC TESTS MARKET
FIGURE 9 RISING PREVALENCE OF TARGET DISEASES AND DISORDERS IS A KEY DRIVER FOR THE OTC TESTS MARKET
FIGURE 10 LATERAL FLOW ASSAYS TO CONTINUE TO DOMINATE THE OTC TESTS
MARKET IN 2024
FIGURE 11 GLUCOSE MONITORING TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN OTC TESTS MARKET IN 2018
FIGURE 12 OTC TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 NORTH AMERICA: OTC TESTS MARKET SNAPSHOT
FIGURE 14 APAC: OTC TESTS MARKET SNAPSHOT
FIGURE 15 OTC TESTS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
FIGURE 16 RANK OF COMPANIES IN THE GLOBAL OTC TESTS MARKET, 2017
FIGURE 17 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2018)
FIGURE 18 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
FIGURE 19 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2017)
FIGURE 20 LABSTYLE INNOVATIONS: COMPANY SNAPSHOT (2017)
